Results 101 to 110 of about 2,254,901 (137)

The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy. [PDF]

Int J Biol Sci
He K, Zhao Z, Bai J, Lu T, Hu Y, He X, Wei F, Zhang Y, Gu Y, Shi Z, Meng X, Wang F, Shi C, Qin W, Zhang K, Xie Q, Yang L.   +16 more
europepmc   +1 more source

Evaluating the contraceptive potential of active immunization against gonadotropin-releasing hormone. [PDF]

Reproduction
Urbanski HF, Slifka MK, Appleman ML, Thomas A, Kohama SG, Erikson DW, Lomniczi A.   +6 more
europepmc   +1 more source

Cardiovascular Complications Associated with Uro-Oncology Treatments-A Primer for the Clinician. [PDF]

Diagnostics (Basel)
Pena DL, Ilieșiu AM, Aurelian J, Grigore M, Hodorogea AS, Coriu-Georgescu C, Weiss E, Badilă E, Jinga V, Balahura AM.   +9 more
europepmc   +1 more source

Targeting androgen receptor signaling to enhance cancer immunotherapy. [PDF]

Trends Pharmacol Sci
Bader DA, Chakraborty B, McDonnell DP, Hirschey MD.   +3 more
europepmc   +1 more source

Taming pet allergens: strategies to make furry cats less allergenic. [PDF]

Front Allergy
Guillet C, Lüthi A, Šošić L, Paolucci M, Kündig TM, Johansen P.   +5 more
europepmc   +1 more source

Serological epidemiology of hepatitis B virus and vaccine-induced immune dynamics in 58,169 children in Wuhan, China (2019-2025): a cross-sectional analysis of waning immunity and adolescent susceptibility. [PDF]

Virol J
Yang J, Wang F, Huang J.
europepmc   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Advances in antimicrobial peptides: promising cancer treatments and vaccines. [PDF]

Front Med (Lausanne)
Ghaly G, Tallima H, Shoeib T.
europepmc   +1 more source

Peptide Therapeutics for Solid Tumors: Functional Classes, AI-Enhanced Discovery and Clinical Advances. [PDF]

J Pept Sci
Liang J, Tang X, Li H, Fang Y, Jiang F.
europepmc   +1 more source

Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrest. [PDF]

Cancer Immunol Immunother
Levite M, Ilouz N, Galun E, Shoshan Y.
europepmc   +1 more source